Biotech China 2014

Rheumatologists have plenty of choice among biologic agents for RA - where will Actemra find its niche?

BioTrends Research Group released topline findings from LaunchTrends®: ACTEMRA, Wave 1 today, highlighting the market uptake of the product at one month post launch. Actemra (tocilizumab), marketed by Roche-Genentech, is a new IL-6 inhibitor with monthly dosing by IV infusion.

http://www.biovalley.ch/content.cfm?nav=4&content=10&command=details&id=12914



Comments

POSTED:2012-10-11 02:59:58

AUTHOR: GUEST

IQYjv5 , [url=http://yflogjwhtbmt.com/]yflogjwhtbmt[/url], [link=http://bopvjiceophj.com/]bopvjiceophj[/link], http://spbzvdceuubw.com/


POSTED:2012-10-10 13:24:42

AUTHOR: GUEST

hr8Yhe <a href="http://ypgoqszbqqxy.com/">ypgoqszbqqxy</a>


POSTED:2012-10-09 05:27:25

AUTHOR: GUEST

WzNCWC , [url=http://ryxkltubhfbk.com/]ryxkltubhfbk[/url], [link=http://vigfnwkgevbn.com/]vigfnwkgevbn[/link], http://ezbkafsabelq.com/


POSTED:2012-10-08 07:27:36

AUTHOR: GUEST

cdgmSa <a href="http://lywwomuawfpj.com/">lywwomuawfpj</a>


POSTED:2012-10-08 00:09:15

AUTHOR: GUEST

most God given country Uganda.How soon is this tanikg place?Is not like other projects which has never gained hope in Uganda?I wll be among those Uganda aspiring and advocating for mother earth.Hope to hear from you soon.


4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.